Our portfolio companies

Portfolio Our portfolio companies

Rigontec

Rigontec

Harnessing one of the most essential pathways in the innate immune system to generate effective therapies.

Rigontec is a privately held biopharmaceutical company that develops RNA-based immunotherapeutics for the treatment of cancer and viral diseases.

  • Industry Biotech